Journal
NEUROBIOLOGY OF AGING
Volume 22, Issue 2, Pages 227-235Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0197-4580(00)00227-X
Keywords
apolipoprotein E; promoter; ThlE47cs; Alzheimer's disease; normal aging; Braak stage
Categories
Ask authors/readers for more resources
We studied whether ApoE and -219 GT (ApoE promoter) polymorphism modulates neurofibrillary tangle (NFT) and senile plaque (SP) development in aging among 190 non-institutionalized individuals (mean age 79.5 years). Analysis revealed that the mean Braak stage was higher in is an element of4 allele carriers. Once individuals with Braak stage V were excluded (n = 5), relationships between NFT and the two genotypes studied were weak, whereas in is an element of4 allele carriers, the risk of SP was multiplied by 4 to 7 in four areas (CA1, subiculum, isocortex and entorhinal cortex). This association was more pronounced in subjects under 80 years and was also observed when analysis was restricted to Braak stages 0, I and II. Epsilon 2 allele carriers appeared to have fewer lesions but, due to limited numbers, this trend was not significant. In two regions (CAI, subiculum), the number of SP increased significantly for individuals who were homozygous for the T allele of -219 GT. However the association was no longer significant when controlling for ApoE is an element of4. It should be noted that the brain of elderly subjects carrying one is an element of4 allele may not undergo senile changes. (C) 2001 Elsevier Science Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available